Balyasny Asset Management
DXCM icon

Balyasny Asset Management’s DexCom DXCM Stock Holding History

Balyasny Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,800
Closed -$1.98M – 3035
2025
Q4 		$1.98M Sell
29,800
-14,400
-33% -$931K ﹤0.01% 1873
2025
Q3 		$2.97M Sell
44,200
-40,600
-48% -$3.21M ﹤0.01% 1622
2025
Q2 		$7.4M Buy
84,800
+22,100
+35% +$1.73M 0.01% 1104
2025
Q1 		$4.28M Buy
62,700
+40,700
+185% +$3.32M 0.01% 1325
2024
Q4 		$1.71M Hold
22,000
– – ﹤0.01% 1733
2024
Q3 		$1.47M Buy
+22,000
New +$1.81M ﹤0.01% 1803
2023
Q2 		– Sell
-520,000
Closed -$60.4M – 2391
2023
Q1 		$60.4M Buy
520,000
+501,900
+2,773% +$56.2M 0.15% 170
2022
Q4 		$2.05M Sell
18,100
-4,100
-18% -$450K 0.01% 1402
2022
Q3 		$1.79M Sell
22,200
-3,800
-15% -$322K 0.01% 1549
2022
Q2 		$1.94M Buy
+26,000
New +$2.37M 0.01% 1438
2018
Q4 		– Sell
-447,200
Closed -$15.5M – 1475
2018
Q3 		$15.5M Buy
+447,200
New +$13.9M 0.07% 358
2018
Q1 		– Sell
-624,800
Closed -$8.96M – 2019
2017
Q4 		$8.96M Buy
624,800
+544,800
+681% +$7.08M 0.03% 670
2017
Q3 		$979K Buy
+80,000
New +$1.41M ﹤0.01% 1167

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Balyasny Asset Management's DXCM Position: Q1 2026 in Review

Balyasny Asset Management reduced its DexCom (DXCM) stake by 44% in Q1 2026, selling an estimated $31.2M and leaving 566,312 shares worth $35.6M. The position accounts for 0.05% of the portfolio, ranked #472.

Balyasny Asset Management first reported a position in DXCM in Q3 2015 and has held it in 29 quarters since. The position peaked at $113M in Q4 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Balyasny Asset Management held 566,312 shares of DexCom worth $35.6M as of Q1 2026.
  • Balyasny Asset Management sold 448,534 DexCom shares in Q1 2026, an estimated $31.2M.
  • DexCom made up 0.05% of Balyasny Asset Management's portfolio in Q1 2026, its #472 holding.
  • Balyasny Asset Management first reported a position in DexCom in Q3 2015 and has held it in 29 quarters since.
  • Balyasny Asset Management's DexCom position peaked at $113M in Q4 2022.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.